FierceBiotech16d
Boehringer's phase 3 schizophrenia program misses primary goal
The phase 3 program missed both primary and key secondary endpoints, with no statistically significant effects on relevant measures observed for patients receiving investigational treatment ...
Medical Xpress18d
Phase III trial finds trastuzumab emtansine improves long-term survival in HER2 breast cancer
according to the final results of the Phase III KATHERINE clinical trial led by researchers from the University of Pittsburgh and UPMC Hillman Cancer Center. "KATHERINE is a landmark clinical ...
Motor Cycle News19d
The future of EV? Honda begins pilot production of all-solid-state batteries in Japan
A collection of unremarkable white factory buildings in Sakura, Japan, could house the key to Honda’s future – all-solid-state EV batteries. In January 2025, it comes to life as a ...
C&EN19d
PET Imaging of Solid Tumors with a G-Quadruplex-Targeting
Guangdong Medicine-Engineering Interdisciplinary Technology Research Center, School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou 510006, China ...
FiercePharma19d
BioDuro boosts peptide production in China with new manufacturing plant
BioDuro, a research and CDMO group, opened a new peptide synthesis manufacturing facility at its campus in the Zhangjiang tech center in Shanghai. The facility expands the company’s peptide ...
C&EN23d
Peptide Backbone Cleavage and Transamidation via Thioester-to-Imide Acyl Transfer
Center for Biopharmaceuticals and Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Jagtvej 160, DK-2100, Copenhagen, Denmark ...